Urology · Charleston, SC
NPI
1104825637
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1470 Tobias Gadson Blvd, Suite 201
Charleston, SC, 29407
Phone (843) 556-7060
Groups this clinician bills Medicare through
Medicare paid, 2024
$295K
8,458 services
Medicare patients, 2024
1,006
Average age 76
Drug cost, 2024
$651K
1,718 prescriptions
Company payments, 2025
$1,605
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark G Buchanan was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,537 times for 822 patients. In total Mark G Buchanan billed 8,458 services in 99 codes, and Medicare paid $295K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,537 | 822 | $11.40 | $18K |
| 81002 Clinical Chemistry | Office | 1,494 | 796 | $3.41 | $5,089 |
| 99214 Office E&M - Established | Office | 968 | 546 | $86.58 | $84K |
| 99213 Office E&M - Established | Office | 704 | 537 | $59.01 | $42K |
| 36415 Venipuncture Blood Collection | Office | 333 | 230 | $8.65 | $2,880 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 267 | 73 | $46.56 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 245 | 200 | $7.26 | $1,780 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 153 | 67 | $35.54 | $5,437 |
| 99204 Office E&M - New | Office | 108 | 108 | $111.13 | $12K |
| 52000 Cystourethroscopy | Office | 60 | 54 | $164.80 | $9,888 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 49 | 16 | $46.39 | $2,273 |
| 51741 Test - Miscellaneous | Office | 49 | 49 | $6.42 | $314 |
| 51728 Other Organ Systems | Office | 37 | 37 | $152.48 | $5,642 |
| 99222 Hospital E&M - Initial | Facility | 28 | 27 | $97.60 | $2,733 |
| 99211 Office E&M - Established | Office | 28 | 28 | $16.45 | $461 |
By year: 2022 $246K for 6,012 services; 2023 $248K for 5,401 services; 2024 $295K for 8,458 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,494 | 796 | $3.41 | $5,089 |
| 36415 Venipuncture Blood Collection | 333 | 230 | $8.65 | $2,880 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark G Buchanan prescribed most often to Medicare patients was Tamsulosin Hcl, with 533 prescriptions and refills. In total Mark G Buchanan wrote 1,718 Medicare prescriptions that cost $651K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 533 | 1,397 | 187 | $8,770 |
| Myrbetriq Mirabegron | 173 | 329 | 51 | $143K |
| Finasteride Generic | 164 | 485 | 58 | $2,148 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 98 | 121 | 81 | $530 |
| Ciprofloxacin Hcl Generic | 93 | 93 | 84 | $324 |
| Solifenacin Succinate Generic | 61 | 115 | 24 | $4,012 |
| Gemtesa Vibegron | 55 | 111 | 23 | $52K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 54 | 96 | 30 | $1,638 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 44 | 44 | 34 | $145 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 31 | 92 | 12 | $914 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 31 | 31 | 21 | $851 |
| Sildenafil Citrate Generic | 26 | 27 | Under 11 | $89.16 |
| Cephalexin Generic | 25 | 39 | 17 | $150 |
| Potassium Citrate Er Potassium Citrate | 24 | 48 | Under 11 | $1,883 |
| Xtandi Enzalutamide | 24 | 24 | Under 11 | $341K |
Brand drugs: - claims; generic drugs: 1,405 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark G Buchanan $1,605 ($1,605 in general payments such as food, travel and fees) from 24 companies. The largest payer was Medtronic, Inc. with $316.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 10 | $316 |
| Olympus America Inc. | 9 | $220 |
| Janssen Biotech, Inc. JNJ | 4 | $116 |
| Bioprotect Medical, Inc. | 2 | $93.23 |
| Pfizer Inc. PFE | 3 | $87.01 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $68.72 |
| Tolmar, Inc. | 2 | $65.53 |
| Teleflex LLC TFX | 1 | $63.49 |
| Astellas Pharma US Inc 4503.T | 2 | $62.63 |
| Ferring Pharmaceuticals Inc. | 2 | $54.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.